Diabetes mellitus is associated with increased ex vivo-platelet aggregation and decreased response to aspirin - antithrombotic potential of ACE-inhibitors and AT1-antagonists.
Skowasch
Dirk
D
Tuleta
Izabela
I
Viktor
Achim
A
Bauriedel
Gerhard
G
Nickenig
Georg
G
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology*; D003327:Coronary Disease; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D005337:Fibrin / Q000037:antagonists & inhibitors*; D006801:Humans; D006973:Hypertension; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*
D000806:Angiotensin-Converting Enzyme Inhibitors; D005337:Fibrin; D001241:Aspirin